Donald T. Lysle - Publications

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Psychoneuroimmunology

112 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Hermes DJ, Yadav-Samudrala BJ, Xu C, Paniccia JE, Meeker RB, Armstrong ML, Reisdorph N, Cravatt BF, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Lysle DT, Fitting S. GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration. Experimental Neurology. 113699. PMID 33736974 DOI: 10.1016/j.expneurol.2021.113699  1
2020 Paniccia JE, Weckstein TN, Lebonville CL, Lysle DT. Female rats express heroin-induced and -conditioned suppression of peripheral nitric oxide production in response to endotoxin challenge. Brain, Behavior, and Immunity. PMID 33039661 DOI: 10.1016/j.bbi.2020.10.009  1
2020 Parekh SV, Paniccia JE, Lebonville CL, Lysle DT. Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning. Psychopharmacology. PMID 32860071 DOI: 10.1007/S00213-020-05645-2  1
2020 Lebonville CL, Paniccia JE, Parekh SV, Wangler LM, Jones ME, Fuchs RA, Lysle DT. Expression Of A Heroin Contextually Conditioned Immune Effect In Male Rats Requires Camkiiα-Expressing Neurons In Dorsal, But Not Ventral, Subiculum And Hippocampal CA1. Brain, Behavior, and Immunity. PMID 32717403 DOI: 10.1016/J.Bbi.2020.07.028  1
2019 Grifasi IR, McIntosh SE, Thomas RD, Lysle DT, Thiele TE, Marshall SA. Characterization of the Hippocampal Neuroimmune Response to Binge-Like Ethanol Consumption in the Drinking in the Dark Model. Neuroimmunomodulation. 1-14. PMID 30625475 DOI: 10.1159/000495210  1
2018 Jones ME, Paniccia JE, Lebonville CL, Reissner KJ, Lysle DT. Chemogenetic manipulation of dorsal hippocampal astrocytes protects against the development of stress-enhanced fear learning. Neuroscience. PMID 30030056 DOI: 10.1016/J.Neuroscience.2018.07.015  1
2017 Jones ME, Lebonville CL, Paniccia JE, Balentine ME, Reissner KJ, Lysle DT. Hippocampal interleukin-1 mediates stress-enhanced fear learning: A potential role for astrocyte-derived interleukin-1β. Brain, Behavior, and Immunity. PMID 28963000 DOI: 10.1016/J.Bbi.2017.09.016  1
2017 Hutson LW, Lebonville CL, Jones ME, Fuchs RA, Lysle DT. Interleukin-1 Signaling in the Basolateral Amygdala is Necessary for Heroin-Conditioned Immunosuppression. Brain, Behavior, and Immunity. PMID 28131792 DOI: 10.1016/J.Bbi.2017.01.017  1
2016 Marshall SA, McKnight KH, Blose AK, Lysle DT, Thiele TE. Modulation of Binge-like Ethanol Consumption by IL-10 Signaling in the Basolateral Amygdala. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 27640210 DOI: 10.1007/S11481-016-9709-2  1
2016 Lebonville CL, Jones ME, Hutson LW, Cooper LB, Lysle DT. Acquisition of Heroin Conditioned Immunosuppression Requires IL-1 Signaling in the Dorsal Hippocampus. Brain, Behavior, and Immunity. PMID 27072068 DOI: 10.1016/J.Bbi.2016.04.005  1
2015 Marshall SA, Casachahua JD, Rinker JA, Blose AK, Lysle DT, Thiele TE. IL-1 receptor signaling in the basolateral amygdala modulates binge-like ethanol consumption in male C57BL/6J mice. Brain, Behavior, and Immunity. PMID 26365025 DOI: 10.1016/J.Bbi.2015.09.006  1
2015 Jones ME, Lebonville CL, Barrus D, Lysle DT. The role of brain interleukin-1 in stress-enhanced fear learning. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1289-96. PMID 25430780 DOI: 10.1038/Npp.2014.317  1
2015 Lebonville C, Szczytkowski-Thomson J, Lysle D, LeeHutson, Fuchs R. Interleukin-1B in the dorsal hippocampus and the conditioned immune effects of heroin Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.383  1
2014 Hutson LW, Szczytkowski JL, Saurer TB, Lebonville C, Fuchs RA, Lysle DT. Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation. Brain, Behavior, and Immunity. 38: 118-24. PMID 24462948 DOI: 10.1016/J.Bbi.2014.01.008  1
2013 Szczytkowski JL, Lebonville C, Hutson L, Fuchs RA, Lysle DT. Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus. Brain, Behavior, and Immunity. 30: 95-102. PMID 23357470 DOI: 10.1016/J.Bbi.2013.01.076  1
2013 Szczytkowski-Thomson JL, Lebonville CL, Lysle DT. Morphine prevents the development of stress-enhanced fear learning. Pharmacology, Biochemistry, and Behavior. 103: 672-7. PMID 23159544 DOI: 10.1016/j.pbb.2012.10.013  1
2011 Szczytkowski JL, Fuchs RA, Lysle DT. Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation. Journal of Neuroimmunology. 237: 47-56. PMID 21722970 DOI: 10.1016/J.Jneuroim.2011.06.002  1
2011 Szczytkowski JL, Lysle DT. Conditioned Immunomodulation Associative Learning and Conditioning Theory: Human and Non-Human Applications. DOI: 10.1093/acprof:oso/9780199735969.003.0067  1
2010 Szczytkowski JL, Lysle DT. Dopamine D1 receptors within the basolateral amygdala mediate heroin-induced conditioned immunomodulation. Journal of Neuroimmunology. 226: 38-47. PMID 20605224 DOI: 10.1016/J.Jneuroim.2010.05.029  1
2009 Saurer TB, Ijames SG, Lysle DT. Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations. The Journal of Pharmacology and Experimental Therapeutics. 329: 1040-7. PMID 19258519 DOI: 10.1124/jpet.108.148627  1
2008 Szczytkowski JL, Lysle DT. Conditioned effects of heroin on proinflammatory mediators require the basolateral amygdala. The European Journal of Neuroscience. 28: 1867-76. PMID 18973600 DOI: 10.1111/J.1460-9568.2008.06472.X  1
2008 Saurer TB, Ijames SG, Carrigan KA, Lysle DT. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation. Brain, Behavior, and Immunity. 22: 89-97. PMID 17689049 DOI: 10.1016/J.Bbi.2007.06.009  1
2007 Ahmed FE, Vos PW, Ijames S, Lysle DT, Flake G, Sinar DR, Naziri W, Marcuard SP. Standardization for transcriptomic molecular markers to screen human colon cancer. Cancer Genomics & Proteomics. 4: 419-31. PMID 18204205  1
2007 Ahmed FE, Vos P, iJames S, Lysle DT, Allison RR, Flake G, Sinar DR, Naziri W, Marcuard SP, Pennington R. Transcriptomic molecular markers for screening human colon cancer in stool and tissue. Cancer Genomics & Proteomics. 4: 1-20. PMID 17726236  1
2007 Lomas LM, Barrett AC, Terner JM, Lysle DT, Picker MJ. Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats. Psychopharmacology. 191: 273-85. PMID 17225166 DOI: 10.1007/S00213-006-0663-1  1
2007 Szczytkowski JL, Lysle DT. Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition. Psychopharmacology. 191: 879-89. PMID 17211650 DOI: 10.1007/S00213-006-0673-Z  1
2006 Elliott JC, Wagner AF, Lysle DT. Neurokinin 1 receptor signaling mediates sex differences in mu and kappa opioid-induced enhancement of contact hypersensitivity. Journal of Neuroimmunology. 181: 100-5. PMID 17023055 DOI: 10.1016/J.Jneuroim.2006.08.011  1
2006 Saurer TB, Ijames SG, Lysle DT. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. Journal of Neuroimmunology. 177: 18-26. PMID 16766046 DOI: 10.1016/j.jneuroim.2006.05.002  1
2006 Elliott JC, Picker MJ, Sparrow AJ, Lysle DT. Dissociation between sex differences in the immunological, behavioral, and physiological effects of kappa- and delta-opioids in Fischer rats. Psychopharmacology. 185: 66-75. PMID 16397747 DOI: 10.1007/S00213-005-0267-1  1
2006 Saurer TB, Carrigan KA, Ijames SG, Lysle DT. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. Journal of Neuroimmunology. 173: 3-11. PMID 16364456 DOI: 10.1016/J.Jneuroim.2005.11.009  1
2004 Ahmed FE, James SI, Lysle DT, Dobbs LJ, Johnke RM, Flake G, Stockton P, Sinar DR, Naziri W, Evans MJ, Kovacs CJ, Allison RR. Improved methods for extracting RNA from exfoliated human colonocytes in stool and RT-PCR analysis. Digestive Diseases and Sciences. 49: 1889-98. PMID 15628722 DOI: 10.1007/S10620-004-9589-9  1
2004 Ahmed FE, Dobbs LJ, Johnke RM, James S, Lysle DT, Sinar DR, Naziri W, Evans MJ, Kovacs CJ, Daly BM, Allison RR. Isolation of circulating colon carcinoma cells for reverse transcriptase polymerase chain reaction. Analytical Biochemistry. 332: 394-7. PMID 15325309 DOI: 10.1016/J.Ab.2004.05.018  1
2004 Carrigan KA, Saurer TB, Ijames SG, Lysle DT. Buprenorphine produces naltrexone reversible alterations of immune status. International Immunopharmacology. 4: 419-28. PMID 15037219 DOI: 10.1016/J.Intimp.2004.01.011  1
2004 Saurer TB, Carrigan KA, Ijames SG, Lysle DT. Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT. Journal of Neuroimmunology. 148: 54-62. PMID 14975586 DOI: 10.1016/J.Jneuroim.2003.11.006  1
2003 Elliott JC, Picker MJ, Nelson CJ, Carrigan KA, Lysle DT. Sex differences in opioid-induced enhancement of contact hypersensitivity. The Journal of Investigative Dermatology. 121: 1053-9. PMID 14708606 DOI: 10.1046/J.1523-1747.2003.12569.X  1
2003 Elliott JC, Ijames SG, Lysle DT. Cocaine increases inducible nitric oxide synthase expression in rats: effects of acute and binge administration. International Immunopharmacology. 3: 1011-8. PMID 12810358 DOI: 10.1016/S1567-5769(03)00099-7  1
2002 Fecho K, Lysle DT. Morphine-induced enhancement in the granulocyte response to thioglycollate administration in the rat. Inflammation. 26: 259-71. PMID 12546135 DOI: 10.1023/A:1021408500630  1
2002 Lysle DT, Ijames SG. Heroin-associated environmental stimuli modulate the expression of inducible nitric oxide synthase in the rat. Psychopharmacology. 164: 416-22. PMID 12457272 DOI: 10.1007/s00213-002-1208-x  1
2002 Lanier RK, Ijames SG, Carrigan KA, Carelli RM, Lysle DT. Self-administration of heroin produces alterations in the expression of inducible nitric oxide synthase. Drug and Alcohol Dependence. 66: 225-33. PMID 12062457 DOI: 10.1016/S0376-8716(01)00203-4  1
2001 Fecho K, Lysle DT. Acute effects of heroin on the cellularity of the spleen and the apoptosis of splenic leukocytes Advances in Experimental Medicine and Biology. 493: 153-162. PMID 11727761 DOI: 10.1007/0-306-47611-8_18  1
2001 Lysle DT, Carrigan KA. Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase. Inflammation. 25: 267-75. PMID 11580103 DOI: 10.1023/A:1010924320902  1
2001 Carrigan KA, Lysle DT. Morphine-6 beta-glucuronide induces potent immunomodulation. International Immunopharmacology. 1: 821-31. PMID 11379038 DOI: 10.1016/S1567-5769(01)00020-0  1
2001 Nelson CJ, Lysle DT. Involvement of substance P and central opioid receptors in morphine modulation of the CHS response. Journal of Neuroimmunology. 115: 101-10. PMID 11282159 DOI: 10.1016/S0165-5728(01)00258-2  1
2001 Nelson CJ, Lysle DT. Morphine modulation of the contact hypersensitivity response: characterization of immunological changes. Clinical Immunology (Orlando, Fla.). 98: 370-7. PMID 11237561 DOI: 10.1006/Clim.2000.4995  1
2000 Nelson CJ, Carrigan KA, Lysle DT. Naltrexone administration attenuates surgery-induced immune alterations in rats. The Journal of Surgical Research. 94: 172-7. PMID 11104658 DOI: 10.1006/Jsre.2000.6003  1
2000 Carrigan KA, Nelson CJ, Lysle DT. Endomorphin-1 induces antinociception without immunomodulatory effects in the rat. Psychopharmacology. 151: 299-305. PMID 11026735 DOI: 10.1007/S002130000487  1
2000 Nelson CJ, Schneider GM, Lysle DT. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation. Brain, Behavior, and Immunity. 14: 170-84. PMID 10970678 DOI: 10.1006/Brbi.1999.0575  1
2000 Fecho K, Lysle DT. Heroin-induced alterations in leukocyte numbers and apoptosis in the rat spleen. Cellular Immunology. 202: 113-23. PMID 10896771 DOI: 10.1006/cimm.2000.1653  1
2000 Fecho K, Nelson CJ, Lysle DT. Phenotypic and functional assessments of immune status in the rat spleen following acute heroin treatment. Immunopharmacology. 46: 193-207. PMID 10741900 DOI: 10.1016/S0162-3109(99)00175-7  1
2000 Lysle DT, How T. Heroin modulates the expression of inducible nitric oxide synthase. Immunopharmacology. 46: 181-92. PMID 10741899 DOI: 10.1016/S0162-3109(99)00172-1  1
1999 West JP, Dykstra LA, Lysle DT. Immunomodulatory effects of morphine withdrawal in the rat are time dependent and reversible by clonidine. Psychopharmacology. 146: 320-7. PMID 10541733 DOI: 10.1007/s002130051123  1
1999 Nelson CJ, How T, Lysle DT. Enhancement of the contact hypersensitivity reaction by acute morphine administration at the elicitation phase. Clinical Immunology (Orlando, Fla.). 93: 176-83. PMID 10527694 DOI: 10.1006/Clim.1999.4783  1
1999 Fecho K, Lysle DT. Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat. Cellular Immunology. 195: 137-46. PMID 10448013 DOI: 10.1006/cimm.1999.1534  1
1999 Petitto JM, Gariepy JL, Gendreau PL, Rodriguiz R, Lewis MH, Lysle DT. Differences in NK cell function in mice bred for high and low aggression: genetic linkage between complex behavioral and immunological traits? Brain, Behavior, and Immunity. 13: 175-86. PMID 10373280 DOI: 10.1006/Brbi.1998.0539  1
1999 Lysle DT, How T. Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes. The Journal of Pharmacology and Experimental Therapeutics. 288: 502-8. PMID 9918551  1
1998 West JP, Dykstra LA, Lysle DT. Differential tolerance to morphine's immunomodulatory effects following continuous administration. Drug and Alcohol Dependence. 53: 31-8. PMID 10933338 DOI: 10.1016/S0376-8716(98)00109-4  1
1998 Nelson CJ, Lysle DT. Severity, time, and beta-adrenergic receptor involvement in surgery-induced immune alterations. The Journal of Surgical Research. 80: 115-22. PMID 9878301 DOI: 10.1006/Jsre.1998.5429  1
1998 Schneider GM, Lysle DT. Role of central mu-opioid receptors in the modulation of nitric oxide production by splenocytes. Journal of Neuroimmunology. 89: 150-9. PMID 9726837 DOI: 10.1016/S0165-5728(98)00128-3  1
1998 Nelson CJ, Dykstra LA, Lysle DT. Morphine's immunologic and analgesic effects. Comparison of time course. Advances in Experimental Medicine and Biology. 437: 169-75. PMID 9666268  1
1997 Fecho K, Maslonek KA, Dykstra LA, Lysle DT. Acetylcholinesterase monoclonal antibody-induced sympathectomy: effects on immune status and acute morphine-induced immunomodulation. Brain, Behavior, and Immunity. 11: 167-84. PMID 9417803 DOI: 10.1006/brbi.1997.0490  1
1997 Perez L, Lysle DT. Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes. Journal of Neuroimmunology. 79: 101-12. PMID 9394782 DOI: 10.1016/S0165-5728(97)00106-9  1
1997 Nelson CJ, Dykstra LA, Lysle DT. Comparison of the time course of morphine's analgesic and immunologic effects. Anesthesia and Analgesia. 85: 620-6. PMID 9296419 DOI: 10.1213/00000539-199709000-00024  1
1997 West JP, Lysle DT, Dykstra LA. Tolerance development to morphine-induced alterations of immune status. Drug and Alcohol Dependence. 46: 147-57. PMID 9250473 DOI: 10.1016/S0376-8716(97)00059-8  1
1996 Schneider GM, Lysle DT. Effects of centrally administered opioid agonists on macrophage nitric oxide production and splenic lymphocyte proliferation. Advances in Experimental Medicine and Biology. 402: 81-8. PMID 8787647 DOI: 10.1007/978-1-4613-0407-4_12  1
1996 Lysle DT, Hoffman KE, Dykstra LA. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. The Journal of Pharmacology and Experimental Therapeutics. 277: 1533-40. PMID 8667220  1
1996 Fecho K, Maslonek KA, Dykstra LA, Lysle DT. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. The Journal of Pharmacology and Experimental Therapeutics. 276: 626-36. PMID 8632330  1
1996 Fecho K, Maslonek KA, Dykstra LA, Lysle DT. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. The Journal of Pharmacology and Experimental Therapeutics. 277: 633-45. PMID 8627540  1
1995 Lysle DT, Coussons-Read ME. Mechanisms of conditioned immunomodulation. International Journal of Immunopharmacology. 17: 641-7. PMID 8847158 DOI: 10.1016/0192-0561(95)00050-C  1
1995 Perez L, Lysle DT. Corticotropin-releasing hormone is involved in conditioned stimulus-induced reduction of natural killer cell activity but not in conditioned alterations in cytokine production or proliferation responses. Journal of Neuroimmunology. 63: 1-8. PMID 8557820 DOI: 10.1016/0165-5728(95)00119-0  1
1995 Fecho K, Maslonek KA, Dykstra LA, Lysle DT. Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation. The Journal of Pharmacology and Experimental Therapeutics. 272: 477-83. PMID 7853159  1
1995 Hoffman KE, Maslonek KA, Dykstra LA, Lysle DT. Effects of central administration of morphine on immune status in Lewis and Wistar rats. Advances in Experimental Medicine and Biology. 373: 155-9. PMID 7668146 DOI: 10.1007/978-1-4615-1951-5_21  1
1995 Fecho K, Maslonek KA, Dykstra LA, Lysle DT. Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced immunomodulation. Advances in Experimental Medicine and Biology. 373: 149-53. PMID 7668145 DOI: 10.1007/978-1-4615-1951-5_20  1
1995 Lysle DT, Fecho K, Maslonek KA, Dykstra LA. Evidence for the involvement of macrophage-derived nitric oxide in the immunomodulatory effect of morphine and aversive Pavlovian conditioning. Advances in Experimental Medicine and Biology. 373: 141-7. PMID 7668144 DOI: 10.1007/978-1-4615-1951-5_19  1
1995 Matta S, Saphier D, Lysle D, Sharp B. The brain-immune axis: role of opiates and other substances of abuse, the hypothalamic-pituitary-adrenal axis and behavior Advances in Experimental Medicine and Biology. 373: 1-9. PMID 7668139  1
1995 Lysle DT. [20] Stressor-induced immune alterations in rodents Methods in Neurosciences. 24: 301-309. DOI: 10.1016/S1043-9471(06)80158-8  1
1994 Coussons-Read ME, Maslonek KA, Fecho K, Perez L, Lysle DT. Evidence for the involvement of macrophage-derived nitric oxide in the modulation of immune status by a conditioned aversive stimulus. Journal of Neuroimmunology. 50: 51-8. PMID 8300858 DOI: 10.1016/0165-5728(94)90214-3  1
1994 Fecho K, Maslonek KA, Coussons-Read ME, Dykstra LA, Lysle DT. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. Journal of Immunology (Baltimore, Md. : 1950). 152: 5845-52. PMID 8207211  1
1994 Petitto JM, Lysle DT, Gariepy JL, Lewis MH. Association of genetic differences in social behavior and cellular immune responsiveness: effects of social experience. Brain, Behavior, and Immunity. 8: 111-22. PMID 8081018 DOI: 10.1006/Brbi.1994.1011  1
1994 Coussons-Read ME, Dykstra LA, Lysle DT. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for peripheral beta-adrenergic receptor involvement. Brain, Behavior, and Immunity. 8: 204-17. PMID 7865892 DOI: 10.1006/brbi.1994.1019  1
1994 Coussons-Read ME, Dykstra LA, Lysle DT. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement. Journal of Neuroimmunology. 55: 135-42. PMID 7829663 DOI: 10.1016/0165-5728(94)90003-5  1
1994 Weber RJ, Lysle DT. Special Issue on Stress, Opioids, and Immune Function - Editorial Comment Brain Behavior and Immunity. 8: 171. DOI: 10.1006/brbi.1994.1016  1
1993 Petitto JM, Lysle DT, Gariepy JL, Clubb PH, Cairns RB, Lewis MH. Genetic differences in social behavior: relation to natural killer cell function and susceptibility to tumor development. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 8: 35-43. PMID 8424847 DOI: 10.1038/Npp.1993.5  1
1993 Fecho K, Dykstra LA, Lysle DT. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. The Journal of Pharmacology and Experimental Therapeutics. 265: 1079-87. PMID 8389851  1
1993 Lysle DT, Coussons ME, Watts VJ, Bennett EH, Dykstra LA. Morphine-induced modulation of immune status: evidence for opioid receptor mediation and compartment specificity. Advances in Experimental Medicine and Biology. 335: 53-9. PMID 8237607 DOI: 10.1007/978-1-4615-2980-4_8  1
1993 Fecho K, Maslonek KA, Dykstra LA, Lysle DT. Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine. Brain, Behavior, and Immunity. 7: 253-70. PMID 8219413 DOI: 10.1006/brbi.1993.1026  1
1993 Lysle DT, Coussons ME, Watts VJ, Bennett EH, Dykstra LA. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. The Journal of Pharmacology and Experimental Therapeutics. 265: 1071-8. PMID 7685383  1
1993 Fecho K, Lysle DT, Dykstra LA. Morphine-induced immune alterations: Evidence for β-adrenergic receptor involvement Nida Research Monograph Series. 296.  1
1993 Coussons ME, Dykstra LA, Lysle DT. Pavlovian conditioning of morphine-induced immune alterations: Evidence for opioid receptor involvement during training Nida Research Monograph Series. 297.  1
1992 Coussons ME, Dykstra LA, Lysle DT. Pavlovian conditioning of morphine-induced alterations of immune status. Journal of Neuroimmunology. 39: 219-30. PMID 1644897 DOI: 10.1016/0165-5728(92)90256-K  1
1992 Petitto JM, Lysle DT, Gariepy JL, Lewis MH. The expression of genetic differences in social behavior in ICR mice correlates with differences in cellular immune responsiveness. Clinical Neuropharmacology. 15: 658A-659A. PMID 1498990  1
1992 Cunnick JE, Lysle DT, Kucinski BJ, Rabin BS. Stress-induced alteration of immune function. Diversity of effects and mechanisms. Annals of the New York Academy of Sciences. 650: 283-7. PMID 1351377 DOI: 10.1111/J.1749-6632.1992.TB49137.X  1
1992 Luecken LJ, Lysle DT. Evidence for the involvement of beta-adrenergic receptors in conditioned immunomodulation. Journal of Neuroimmunology. 38: 209-19. PMID 1351060 DOI: 10.1016/0165-5728(92)90014-C  1
1992 Lysle DT, Luecken LJ, Maslonek KA. Modulation of immune status by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids. Brain, Behavior, and Immunity. 6: 179-88. PMID 1324030 DOI: 10.1016/0889-1591(92)90017-I  1
1992 Lysle DT, Luecken LJ, Maslonek KA. Suppression of the development of adjuvant arthritis by a conditioned aversive stimulus. Brain, Behavior, and Immunity. 6: 64-73. PMID 1315181 DOI: 10.1016/0889-1591(92)90060-2  1
1991 Cunnick JE, Lysle DT, Armfield A, Rabin BS. Stressor-induced changes in mitogenic activity are not associated with decreased interleukin 2 production or changes in lymphocyte subsets. Clinical Immunology and Immunopathology. 60: 419-29. PMID 1864018 DOI: 10.1016/0090-1229(91)90098-U  1
1991 Lysle DT, Cunnick JE, Maslonek KA. Pharmacological manipulation of immune alterations induced by an aversive conditioned stimulus: evidence for a beta-adrenergic receptor-mediated Pavlovian conditioning process. Behavioral Neuroscience. 105: 443-9. PMID 1650562 DOI: 10.1037/0735-7044.105.3.443  1
1991 Lysle DT, Maslonek KA. Immune alterations induced by a conditioned aversive stimulus: Evidence for a time-dependent effect Psychobiology. 19: 339-344. DOI: 10.3758/BF03332090  1
1991 Lysle DT, Cunnick JE. Stress-induced alterations of immune function: Animal models Clinical Immunology Newsletter. 11: 177,180. DOI: 10.1016/0197-1859(91)90018-N  1
1990 Antelman SM, Cunnick JE, Lysle DT, Caggiula AR, Knopf S, Kocan DJ, Rabin BS, Edwards DJ. Immobilization 12 days (but not one hour) earlier enhanced 2-deoxy-D-glucose-induced immunosuppression: evidence for stressor-induced time-dependent sensitization of the immune system. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 14: 579-90. PMID 2236585 DOI: 10.1016/0278-5846(90)90009-6  1
1990 Cunnick JE, Lysle DT, Kucinski BJ, Rabin BS. Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral beta-adrenergic receptors. Pharmacology, Biochemistry, and Behavior. 36: 645-51. PMID 2165621 DOI: 10.1016/0091-3057(90)90270-R  1
1990 Lysle DT, Cunnick JE, Rabin BS. Stressor-induced alteration of lymphocyte proliferation in mice: evidence for enhancement of mitogenic responsiveness. Brain, Behavior, and Immunity. 4: 269-77. PMID 2092863 DOI: 10.1016/0889-1591(90)90031-K  1
1990 Rabin BS, Ganguli R, Lysle DT, Cunnick JE. Interaction between the brain and the immune system. Immunology Series. 52: 125-54. PMID 2091777  1
1990 Lysle DT, Cunnick JE, Kucinski BJ, Fowler H, Rabin BS. Characterization of immune alterations induced by a conditioned aversive stimulus Psychobiology. 18: 220-226. DOI: 10.3758/BF03327230  1
1989 Rabin BS, Cohen S, Ganguli R, Lysle DT, Cunnick JE. Bidirectional interaction between the central nervous system and the immune system. Critical Reviews in Immunology. 9: 279-312. PMID 2679662  1
1988 Lysle DT, Cunnick JE, Fowler H, Rabin BS. Pavlovian conditioning of shock-induced suppression of lymphocyte reactivity: acquisition, extinction, and preexposure effects. Life Sciences. 42: 2185-94. PMID 3374253 DOI: 10.1016/0024-3205(88)90369-4  1
1988 Rabin BS, Ganguli R, Cunnick JE, Lysle DT. The central nervous system--immune system relationship. Clinics in Laboratory Medicine. 8: 253-68. PMID 3284696 DOI: 10.1016/S0272-2712(18)30682-6  1
1988 Lysle DT, Cunnick JE, Wu R, Caggiula AR, Wood PG, Rabin BS. 2-deoxy-D-glucose modulation of T-lymphocyte reactivity: differential effects on lymphoid compartments. Brain, Behavior, and Immunity. 2: 212-21. PMID 3266559 DOI: 10.1016/0889-1591(88)90023-2  1
1988 Cunnick JE, Lysle DT, Armfield A, Rabin BS. Shock-induced modulation of lymphocyte responsiveness and natural killer activity: differential mechanisms of induction. Brain, Behavior, and Immunity. 2: 102-13. PMID 3266082 DOI: 10.1016/0889-1591(88)90011-6  1
1988 Lysle DT, Fowler H. Changes in pain reactivity induced by unconditioned and conditioned excitatory and inhibitory stimuli. Journal of Experimental Psychology. Animal Behavior Processes. 14: 376-89. PMID 3183578 DOI: 10.1037/0097-7403.14.4.376  1
1988 Antelman SM, Knopf S, Caggiula AR, Kocan D, Lysle DT, Edwards DJ. Stress and enhanced dopamine utilization in the frontal cortex: the myth and the reality. Annals of the New York Academy of Sciences. 537: 262-72. PMID 3059928 DOI: 10.1111/J.1749-6632.1988.Tb42112.X  1
1987 Lysle DT, Lyte M, Fowler H, Rabin BS. Shock-induced modulation of lymphocyte reactivity: suppression, habituation, and recovery. Life Sciences. 41: 1805-14. PMID 3498870 DOI: 10.1016/0024-3205(87)90699-0  1
1985 Lysle DT, Fowler H. Inhibition as a "slave" process: deactivation of conditioned inhibition through extinction of conditioned excitation. Journal of Experimental Psychology. Animal Behavior Processes. 11: 71-94. PMID 2578010 DOI: 10.1037/0097-7403.11.1.71  1
Show low-probability matches.